Top Story


New Independent Study Correlates THC in Breath and Blood using Cannabix Technology

May 16th, 2022 - Ryan Allway

The legalization of cannabis promises to solve many of society’s problems and unlock new economic opportunities. However, the move also creates new challenges for law enforcement. For instance, studies suggest that cannabis may acutely impair several driving-related skills in a dose-related fashion, but there’s no easy roadside test available. Cannabix Technologies Inc. (CSE: BLO) (OTC: […]

Why You Should Invest in Europe’s Cannabis Industry (and Its Upcoming Leader)

April 25th, 2022 - Ryan Allway

  The North American cannabis industry has struggled over the past couple of years, but fundamentals are improving and valuations are becoming attractive. As North America continues to grapple with excess supply issues, challenging margins and regulations, investors are starting to turn their attention toward European markets that are in the early innings of adoption […]

CFN Media Sits Down with Hero’s Blackbox CEO Marc Kasabasic to Discuss the Company’s Unique Technology

April 1st, 2022 - Robin Lefferts

Hero Technologies Inc. (OTC: HENC) is focused on building a vertically integrated cannabis operation in Michigan that will expand to become a multi-state operation. The company is currently in the midst of the licensing process in Michigan. In anticipation of receiving the appropriate licenses, Hero has been laying the groundwork for construction of a large […]

New Player in the Michigan Cannabis Market

March 14th, 2022 - Robin Lefferts

The state of Michigan is one of the hottest legal cannabis markets in the United States. According to Andrew Brisbo, Executive Director of Michigan’s Marijuana Regulatory Agency, the state recently passed the $3 billion dollar mark in total sales since October 2018. For 2021 alone, total sales topped $1.79 billion. The industry has been growing […]

PsyBio Therapeutics Reports Annual 2021 Financial Results

March 2nd, 2022 - Ryan Allway

OXFORD, Ohio and COCONUT CREEK, Fla., March 2, 2022 /CNW/ – PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) (“PsyBio” or the “Company“), an integrated and intellectual property driven biotechnology company developing novel, bespoke psychoactive medicinal candidates targeting the potential treatment of mental health challenges, neurological disorders and other human health conditions, today announces that it […]

Revitalist Executes on Mission to Build a National Network of Ketamine Clinics

January 28th, 2022 - Ryan Allway

Psychedelics have shown tremendous promise in treating depression, anxiety, post-traumatic stress disorder, and a range of other mental health conditions. In particular, assisted psychotherapy combines psychedelic substances with talk therapy to facilitate breakthroughs and help patients that don’t see relief through conventional treatments. While psilocybin, MDMA, and other psychedelic medicines remain in clinical trials, the […]

NutraLife Accelerates Expansion into the Rapidly Growing $11 Billion CBD Industry

January 10th, 2022 - Ryan Allway

CBD has become one of the fastest-growing wellness products globally, reaching more than $11 billion in global sales last year. According to Market Data Forecast, these sales will continue to grow at a 22.2% annual pace to nearly $31 billion by 2026. As a result, companies building an early presence in the industry could be […]

3 Ways to Invest in Ketamine Clinics

January 6th, 2022 - Ryan Allway

Researchers believe that psychedelics may revolutionize mental health treatments, but FDA-approved psychedelics remain out of reach—with one exception. Unlike psilocybin or MDMA, ketamine is FDA-approved for anesthesia during medical procedures, opening the door to off-label use as a treatment for depression and other mental illnesses. With the FDA’s approval of Spravato and a growing body […]

How to Capitalize on Europe’s Exploding CBD Market

December 28th, 2021 - Ryan Allway

  Europe is the second-largest CBD market in the world after North America, with over 500 million potential customers. According to Brightfield Group, the European CBD market will grow from €270 million in 2018 to €1.4 billion by 2023, representing a blistering 42% compound annual growth rate, making it one of the fastest-growing markets. While […]

CBD Life Sciences Doubles Down on Self-Service with CBD Vending Machine & Bitcoin ATMs

December 15th, 2021 - Ryan Allway

CBD Life Sciences Inc. (OTC Pink: CBDL) operates a brick-and-mortar CBD store in Scottsdale, Arizona, and an online shop at LBLBioscienceInc.com. While many companies are content with these distribution channels, the company continues to innovate with new self-service machines targeting both CBD and crypto sectors. Let’s look at how these moves could pay off over […]

Flora Growth Builds a Pathway to Unlocking Shareholder Value

December 13th, 2021 - Ryan Allway

  The global cannabis industry will generate more than $30 billion in sales this year according to BDS Analytics, representing a 41% increase over last year’s numbers. While expanding cannabis legalization has been accompanied by a surge in new companies stepping into  the space, few are better positioned than Flora Growth Corp. (NASDAQ: FLGC) with […]

Revitalist Executes on Vision to Become a Clinical Leader in Psychedelics

December 10th, 2021 - Ryan Allway

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) set out to build a nationwide network of psychedelic-assisted psychotherapy clinics in 2018. Since then, the company has grown its footprint to ten clinics across six states exceeding 60,650 sq. ft. of space and clinical capacity for more than 120 treatment rooms, with more […]

PODA Offers a New Take on Heat-Not-Burn Products

December 8th, 2021 - Ryan Allway

Countries worldwide are adopting tobacco harm reduction policies to reduce smoking-related deaths and diseases. While smoking prevention and cessation are the centerpieces of these strategies, scientists believe that public health outcomes among smokers could significantly improve if they switch to non-combustible alternatives. Heat-not-burn products, such as Philip Morris’ IQOS, may reduce exposure to harmful chemicals […]

Craft Cannabis is the Future & Micro-Cultivators Will Lead the Way

December 3rd, 2021 - Ryan Allway

  Canada’s legal cannabis industry is flooded with products that prioritize profits over quality. While many consumers are price-sensitive, Deloitte Canada found that 86% of Millennial and Gen Z consumers are willing to buy premium products. These trends mirror many other industries where premium products are beating out generic competitors. Maven Brands Inc. (CSE: MJ) […]

While Psychedelics Wait, Ketamine Revenues Roll On

November 30th, 2021 - Ryan Allway

The nature of the psychedelic market today means that public company investors are making largely speculative investments. Though there are plenty of studies demonstrating the efficacy of substances ranging from LSD to psilocybin to MDMA, the fact remains they are Schedule 1 controlled substances and have not been approved for therapeutic use. Companies seeking such […]

Vape Industry Uncertainty Could Benefit PODA Alternative

November 16th, 2021 - Robin Lefferts

Vape issues, from teens taking up the habit in large numbers to health concerns, were dominating headlines a couple years back. In response to the industry’s sudden boom and the potential problems associated with vape use, the US Food and Drug Administration (FDA) created a set of standards and a new process for approving vape […]

WestCann: A Unique Business Model with Plenty of Catalysts Ahead

November 11th, 2021 - Ryan Allway

The legal cannabis industry has grown from humble beginnings in the early 2000s into a multi-billion dollar global industry. In addition to THC-containing products capturing market share from the black market, CBD and other cannabinoids have exploded onto the health and wellness scene as researchers continue to uncover potential benefits. Of course, a license to […]

Maven Brands Unleashes the Potential of Craft Micro-Cultivators in Canada

November 10th, 2021 - Ryan Allway

Micro-cultivators have become one of the fastest-growing segments of the cannabis industry. Consumers strongly prefer craft cannabis after the explosion of low-quality and over-priced products hit the retail market following legalization. Unfortunately, many restrictions and obstacles keep micro-cultivators from reaching the market. Newly re-branded Maven Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FSE: TLAA) is […]

Teen THC Vaping on the Rise: Solutions Beyond Government Regulations

November 9th, 2021 - Ryan Allway

Teen vaping of marijuana doubled between 2013 and 2020, according to a new study. In addition to harmful side effects, these trends are compounding problems that governments and businesses are already struggling with among the legal cannabis-consuming population. Fortunately, new technologies could be on the way to help detect and deter illegal use. Let’s look […]

Revitalist Brings Together Impressive Team to Improve Mental Health

November 8th, 2021 - Ryan Allway

Mental health disorders account for several of the top causes of disability in the U.S. and worldwide. In fact, 26% of Americans ages 18 and older—or about one in four adults—have a diagnosable mental disorder in a given year. In addition, nearly 10% of American adults will also suffer from a depressive illness, such as […]

Silo Pharma’s Sponsored Research Agreement with Columbia Could Yield a New Alzheimer’s Disease Treatment

November 3rd, 2021 - Ryan Allway

Alzheimer’s disease is the sixth leading cause of death in the U.S. and a leading cause of disability and poor health. By 2050, iHealthcareAnalyst projects the number of people suffering from AD will reach 14 million in the U.S. alone. Yet, despite significant investment in clinical trials, the FDA has only approved two types of […]

PODA: The Evolution of Smoking

October 25th, 2021 - Robin Lefferts

By now we all know that smoking tobacco is bad for your health. After years of famously covering up the science proving this fact, even the tobacco industry has come around on the issue. Philip Morris, the world’s largest tobacco company, now touts a ‘vision of a smoke-free future’ and has introduced heat-not-burn (HNB) products […]

How to Solve the Trucking Industry’s Cannabis Problem

October 22nd, 2021 - Ryan Allway

  The federal government heavily regulates the trucking industry. For instance, drivers have to log how many hours they’ve rested each day to ensure they meet mandatory minimums. Therefore, it’s not surprising that the Department of Transportation prohibits drivers from using any Schedule I substance and subjects all drivers to drug testing. In January of […]

WestCann brings THC & CBD hemp cigarettes to the U.S. and Canadian markets

October 21st, 2021 - Ryan Allway

The global cannabis industry is projected to reach nearly $20 billion in value this year and grow at a 27% compound annual growth rate through 2030, according to Quince Market Insights. But rather than focusing on industry giants, investors may want to take a closer look at niche corners of the market where innovators could […]

Flora Growth Looks to Bridge the Gap Between Cannabis & Pharmaceuticals

October 15th, 2021 - Ryan Allway

  Cannabis-based pharmaceutical drug products remain a niche market despite the plant’s significant promise. By acting on the endocannabinoid system, a widespread neuromodulator that plays an important role in everything from central nervous system development to synaptic plasticity, cannabinoids have the potential to treat a wide range of conditions. Dronabinol, a synthetic version of THC, […]

Building the DoorDash or UberEats of Psychedelics

October 14th, 2021 - Ryan Allway

The psychedelics industry is rapidly growing, with more than 50 publicly traded companies worth billions of dollars. At the same time, the FDA’s approval of Spravato (esketamine) for treatment-resistant depression and the growing body of clinical evidence could provide further tailwinds for the industry over the coming decade and beyond. Unfortunately, many patients live in […]

BioHarvest Looks to Make Cannabis More Sustainable

October 13th, 2021 - Ryan Allway

Investors have become increasingly environmentally conscious over the past few years, evidenced by the tremendous growth in ESG funds. But, unfortunately, investors in the cannabis industry may be surprised by its significant environmental impact. Fortunately, many companies are working to improve the situation and make the industry more “green.” Let’s take a closer look at […]

Heat-Not-Burn Could Replace Vapes to Help Adult Smokers Reduce Risk without Attracting Youth, Non-Smokers

October 12th, 2021 - Ryan Allway

Most adults and regulators recognize the harm of tobacco, but flavored high-nicotine vaping products have evaded regulatory scrutiny. While the U.K., Europe, and Canada outlawed vape products containing high nicotine levels, the FDA only recently denied marketing approval for hundreds of vape brands and ordered them off store shelves. The new FDA ban prevents many […]

Cannabis Legalization Linked to Increase in Fatal Motor Vehicle Collisions

October 6th, 2021 - Ryan Allway

Most people that have used recreational cannabis know of its mind-altering effects. So, it shouldn’t come as a surprise that driving under the influence of marijuana can at least disrupt traffic and, at worst, lead to an increase in fatal motor vehicle collisions. A recent study published in the Canadian Medical Association Journal confirmed these […]

Silo Pharma Looks to Become a NASDAQ Biotech

October 4th, 2021 - Ryan Allway

Silo Pharma Inc. (OTCQB: SILO) is a cutting-edge, development-stage biotechnology company focused on merging traditional therapeutics with emerging psychedelic research for people suffering from indicators such as depression, post-traumatic stress disorder, Parkinson’s disease, and other rare neurological disorders, representing billion-dollar markets. The company submitted an initial application to list on the NASDAQ Capital Market—a move […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading